MULTIPURPOSE SHOWER HEAD FIXING DEVICE AND SHOWER FIXING DEVICE

    公开(公告)号:US20210023579A1

    公开(公告)日:2021-01-28

    申请号:US16661970

    申请日:2019-10-23

    申请人: Qin Yu

    发明人: Qin Yu jing Guo

    IPC分类号: B05B15/62 F16K11/00

    摘要: A multipurpose shower head fixing device and a shower fixing device are provided, wherein the shower head fixing device comprises a connecting and fixing piece having a wrench structure and a shower head connecting mechanism, and the shower fixing device comprises a switching valve and the shower head fixing device. According to the invention, the structure with a wrench function is additionally provided on the connecting and fixing piece, thus, when the multipurpose shower head fixing device works with the switching valve cooperatively, no wrench is needed additionally, and a locking nut of the switching valve can be locked when the locking nut is matched with the wrench structure of the connecting and fixing piece.

    FUNCTION AND REGULATION OF ADAMTS-1
    12.
    发明申请
    FUNCTION AND REGULATION OF ADAMTS-1 审中-公开
    ADAMTS-1的功能和调节

    公开(公告)号:US20140294846A1

    公开(公告)日:2014-10-02

    申请号:US14183341

    申请日:2014-02-18

    申请人: Qin Yu

    发明人: Qin Yu

    摘要: The present invention relates to ADAMTS-1 and uses thereof. The present invention also relates to fragments of ADAMTS-1 and methods of inhibiting cell growth and metastasis. The present invention also provide methods of identifying inhibitors and activators relating to the function of ADAMTS-1.

    摘要翻译: 本发明涉及ADAMTS-1及其用途。 本发明还涉及ADAMTS-1的片段和抑制细胞生长和转移的方法。 本发明还提供鉴定与ADAMTS-1的功能相关的抑制剂和活化剂的方法。

    METHODS OF USING CD44 FUSION PROTEINS TO TREAT CANCER
    13.
    发明申请
    METHODS OF USING CD44 FUSION PROTEINS TO TREAT CANCER 审中-公开
    使用CD44融合蛋白治疗癌症的方法

    公开(公告)号:US20120207753A1

    公开(公告)日:2012-08-16

    申请号:US13391144

    申请日:2010-08-16

    摘要: Pharmaceutical compositions and methods for treating cancer using CD44 antagonists are disclosed. In certain aspects, these pharmaceutical compositions and methods include treating a mammal having a cancer, such as glioma, colon cancer, breast cancer, prostate cancer, ovarian cancer, lung cancer, renal cell carcinoma, gastric cancer, esophageal cancer, head cancer, neck cancer, pancreatic cancer, or melanoma, with a CD44 fusion protein. These CD44 fusion proteins include CD44-Fc fusions and can be used to detect hyaluronan.

    摘要翻译: 公开了使用CD44拮抗剂治疗癌症的药物组合物和方法。 在某些方面,这些药物组合物和方法包括治疗具有癌症的哺乳动物,例如胶质瘤,结肠癌,乳腺癌,前列腺癌,卵巢癌,肺癌,肾细胞癌,胃癌,食管癌,头癌,颈部 癌症,胰腺癌或黑色素瘤,具有CD44融合蛋白。 这些CD44融合蛋白包括CD44-Fc融合体,可用于检测透明质酸。

    Dynamic return type generation in a database system
    16.
    发明授权
    Dynamic return type generation in a database system 有权
    数据库系统中的动态返回类型生成

    公开(公告)号:US07689542B2

    公开(公告)日:2010-03-30

    申请号:US10767512

    申请日:2004-01-29

    IPC分类号: G06F17/30

    摘要: Dynamic return type generation in a database system. A request is received to execute a first function. A second function is executed if the first function is defined to return data in a first type of data structure. When executed, the second function returns formatting information that indicates an arrangement of fields of data within the first type of data structure. The first function is executed to obtain a collection of data formatted according to the first type of data structure, and the collection of data is organized according to the formatting information returned by the second function.

    摘要翻译: 数据库系统中的动态返回类型生成。 接收到执行第一功能的请求。 如果第一个函数定义为返回第一类数据结构中的数据,则执行第二个函数。 当执行时,第二功能返回指示第一类型的数据结构内的数据的排列的格式化信息。 执行第一功能以获得根据第一类型的数据结构格式化的数据的集合,并且根据由第二功能返回的格式化信息来组织数据的收集。

    Dynamic return type generation in a database system
    17.
    发明申请
    Dynamic return type generation in a database system 有权
    数据库系统中的动态返回类型生成

    公开(公告)号:US20050154715A1

    公开(公告)日:2005-07-14

    申请号:US10767512

    申请日:2004-01-29

    IPC分类号: G06F7/00 G06F17/30

    摘要: Dynamic return type generation in a database system. A request is received to execute a first function. A second function is executed if the first function is defined to return data in a first type of data structure. When executed, the second function returns formatting information that indicates an arrangement of fields of data within the first type of data structure. The first function is executed to obtain a collection of data formatted according to the first type of data structure, and the collection of data is organized according to the formatting information returned by the second function.

    摘要翻译: 数据库系统中的动态返回类型生成。 接收到执行第一功能的请求。 如果第一个函数定义为返回第一类数据结构中的数据,则执行第二个函数。 当执行时,第二功能返回指示第一类型的数据结构内的数据的排列的格式化信息。 执行第一功能以获得根据第一类型的数据结构格式化的数据的集合,并且根据由第二功能返回的格式化信息来组织数据的收集。

    REGULATION OF FUNCTION OF ANGIOPOIETIN
    19.
    发明申请
    REGULATION OF FUNCTION OF ANGIOPOIETIN 审中-公开
    血管平滑肌细胞功能的调节

    公开(公告)号:US20100210520A9

    公开(公告)日:2010-08-19

    申请号:US12211073

    申请日:2008-09-15

    申请人: Qin Yu

    发明人: Qin Yu

    CPC分类号: C07K14/515 A61K38/00

    摘要: Pharmaceutical compositions that comprise a pharmaceutically acceptable carrier and either a therapeutically effective amount of an ECM-binding fragment of Ang-1 protein that comprises SEQ ID NO:1 and/or SEQ ID NO:2 or a homologous peptide thereof and pharmaceutical compositions that comprise a pharmaceutically acceptable carrier and a vector comprising a nucleic acid molecule that comprises the nucleotide sequence that encodes an ECM-binding fragment of Ang-1 protein that comprises SEQ ID NO:1 and/or SEQ ID NO:2 or a homologous peptide thereof are disclosed. Methods of using such compositions to treat individuals suspected of having coronary artery disease, vascular disease or a condition involving ischemia and to promote angiogenesis, endothelial survival and maintaining vascular integrity are disclosed. Methods to identify compounds that modulates binding of Ang-1 to ECM are disclosed. Pharmaceutical compositions which comprise a therapeutically effective amount of Ang-2 protein and/or a vector comprising a nucleic acid molecule that comprises the nucleotide coding sequence of Ang-2 and methods of using such compositions to treat individuals suspected of having cancer are disclosed.

    摘要翻译: 包含药学上可接受的载体和治疗有效量的包含SEQ ID NO:1和/或SEQ ID NO:2的Ang-1蛋白的ECM结合片段或其同源肽的药物组合物和包含 药学上可接受的载体和载体,其包含核酸分子,其包含编码包含SEQ ID NO:1和/或SEQ ID NO:2或其同源肽的Ang-1蛋白的ECM结合片段的核苷酸序列 披露 公开了使用这些组合物治疗怀疑有冠状动脉疾病,血管疾病或涉及缺血的病症并促进血管发生,内皮存活和维持血管完整性的方法。 公开了鉴定调节Ang-1与ECM结合的化合物的方法。 公开了包含治疗有效量的Ang-2蛋白和/或包含含有Ang-2的核苷酸编码序列的核酸分子的载体的药物组合物和使用该组合物治疗疑似患有癌症的个体的方法。

    Partitioning of nested tables
    20.
    发明授权
    Partitioning of nested tables 有权
    嵌套表的分区

    公开(公告)号:US07756889B2

    公开(公告)日:2010-07-13

    申请号:US11707735

    申请日:2007-02-16

    IPC分类号: G06F7/00

    CPC分类号: G06F17/30486 G06F17/30312

    摘要: Techniques for partitioning nested tables are provided. A parent table includes a column for collection items. A nested table is created for storing items that belong to the collection items. The nested table is partitioned to create a plurality of nested table partitions. Each nested table partition is a distinct, separately stored structure within a database. How the nested table is partitioned may, or may not, be based on how the parent table is partitioned. For example, a nested table may be partitioned based on the same criteria in which the parent table is partitioned. As another example, a nested table may be partitioned, whereas the parent table is not partitioned.

    摘要翻译: 提供分区嵌套表的技术。 父表包括收集项列。 创建嵌套表用于存储属于集合项目的项目。 嵌套表被分区以创建多个嵌套表分区。 每个嵌套表分区是一个不同的,单独存储的数据库结构。 嵌套表的分区方式可能是,也可能不是基于父表的分区方式。 例如,嵌套表可以根据父表进行分区的相同标准进行分区。 作为另一示例,嵌套表可以被分区,而父表不被分区。